WINDSOR JAMES BRIAN
See Remarks
WINDSOR JAMES BRIAN has filed 1 SEC Form 4 filing (1 transaction rows) across 1 company, with disclosures dating back to 2026. 1 of those filings fall inside the rolling window. Most recent filing: May 13, 2026.
On the most recent filing, WINDSOR JAMES BRIAN is listed as See Remarks at Rein Therapeutics, Inc. Inside the rolling window, WINDSOR JAMES BRIAN reported 1 open-market purchase totaling $25K in RNTX and no open-market sales.
Companies traded
Other insiders at RNTX
Insider Buying
$25K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has WINDSOR JAMES BRIAN made?
WINDSOR JAMES BRIAN has filed 1 SEC Form 4 filing (1 transaction rows) across 1 company since 2026.
Which companies does WINDSOR JAMES BRIAN trade?
WINDSOR JAMES BRIAN has filed SEC Form 4 disclosures for 1 company, including RNTX.
When was WINDSOR JAMES BRIAN's most recent SEC Form 4 filing?
WINDSOR JAMES BRIAN's most recent SEC Form 4 filing on Tracefour is dated May 13, 2026.
What is WINDSOR JAMES BRIAN's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, WINDSOR JAMES BRIAN is listed as See Remarks.
What is WINDSOR JAMES BRIAN's total buy and sell value in the current window?
Inside the rolling retention window, WINDSOR JAMES BRIAN bought $25K and sold $0 based on SEC Form 4 filings.
What was WINDSOR JAMES BRIAN's largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 25,000 RNTX shares on 2026-04-30, worth $25K, per SEC Form 4 filings.